1 H NMR and HPLC/DAD for Cannabis sativa L. chemotype distinction, extract profiling and specification
- 1 August 2015
- journal article
- Published by Elsevier BV in Talanta
- Vol. 140, 150-165
- https://doi.org/10.1016/j.talanta.2015.02.040
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Δ9‐Tetrahydrocannabivarin suppresses in vitro epileptiform and in vivo seizure activity in adult ratsEpilepsia, 2010
- Beta-caryophyllene is a dietary cannabinoidProceedings of the National Academy of Sciences of the United States of America, 2008
- The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: Δ9‐tetrahydrocannabinol, cannabidiol and Δ9‐tetrahydrocannabivarinBritish Journal of Pharmacology, 2008
- Chemical constituents of marijuana: The complex mixture of natural cannabinoidsLife Sciences, 2005
- Quantitative NMR spectroscopy—Applications in drug analysisJournal of Pharmaceutical and Biomedical Analysis, 2005
- Cannabinerolic acid, a cannabinoid from Cannabis sativaPhytochemistry, 1995
- High Performance Liquid Chromatographic Profiling of Cannabis ProductsJournal of Liquid Chromatography, 1995
- Investigation of Hashish: Content Uniformity of Different Samples by Coupled HPLC/PC‐AnalysisArchiv der Pharmazie, 1991
- Identification of a New Chemotype inCannabis sativa: Cannabigerol - Dominant Plants, Biogenetic and Agronomic ProspectsPlanta Medica, 1987
- Constituents of Cannabis sativa L. XI: Cannabidiol and Cannabichromene in Samples of Known Geographical OriginJournal of Pharmaceutical Sciences, 1975